British Drugmaker GSK Said the Laboratory Analysis of the Antibody-based COVID-19 Therapy ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'British drugmaker GSK said the laboratory analysis of the antibody-based COVID-19 therapy it is developing with U.S. partner Vir has indicated the drug is effective against the new Omicron variant ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)